On the public citation graph
A pharmacovigilance study of association between proton‐pump inhibitors and rhabdomyolysis event based on FAERS database
0 signed · 47 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/pds.2014openalex-snapshot
Selected control events and reporting odds ratio in signal detection methodology
inferredcites →https://doi.org/10.1002/pds.668openalex-snapshot
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
inferredcites →https://doi.org/10.1002/pds.677openalex-snapshot
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
inferredcites →https://doi.org/10.1002/sim.2473openalex-snapshot
Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events
inferredcites →https://doi.org/10.1007/s00134-010-1854-0openalex-snapshot
Esomeprazole-induced rhabdomyolysis in a patient with heart failure
inferredcites →https://doi.org/10.1007/s00228-006-0131-1openalex-snapshot
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
inferredcites →https://doi.org/10.1007/s002280050466openalex-snapshot
A Bayesian neural network method for adverse drug reaction signal generation
inferredcites →https://doi.org/10.1007/s40264-014-0180-9openalex-snapshot
Safety Signal Detection: The Relevance of Literature Review
inferredcites →https://doi.org/10.1007/s40264-016-0473-2openalex-snapshot
Proton Pump Inhibitors and Risk of Rhabdomyolysis
inferredcites →https://doi.org/10.1007/s40264-017-0564-8openalex-snapshot
Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database
inferredcites →https://doi.org/10.1016/j.ajem.2007.08.026openalex-snapshot
Proton pump inhibitor–induced rhabdomyolysis and hyponatremic delirium
inferredcites →https://doi.org/10.1016/j.ajem.2018.12.061openalex-snapshot
An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2010.10.704openalex-snapshot
Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure
inferredcites →https://doi.org/10.1016/s0140-6736(94)92008-7openalex-snapshot
Autoimmune syndrome induced by omeprazole
inferredcites →https://doi.org/10.1023/a:1011036428972openalex-snapshot
HMG-CoA Reductase Inhibitors (Statins) Characterized as Direct Inhibitors of P-Glycoprotein
inferredcites →https://doi.org/10.1097/md.0000000000004313openalex-snapshot
Rhabdomyolysis associated with single-dose intravenous esomeprazole administration
inferredcites →https://doi.org/10.1111/apt.16601openalex-snapshot
Bevacizumab and gastrointestinal perforations: a review from the FDA Adverse Event Reporting System (FAERS) database
inferredcites →https://doi.org/10.1111/j.1365-2125.2011.04037.xopenalex-snapshot
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
inferredcites →https://doi.org/10.1124/dmd.32.8.821openalex-snapshot
COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES
inferredcites →https://doi.org/10.1152/ajpheart.1997.272.2.h869openalex-snapshot
Molecular evidence for a vascular smooth muscle H+-K+-ATPase
inferredcites →https://doi.org/10.1177/10600280231156270openalex-snapshot
Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases
inferredcites →https://doi.org/10.1177/20420986231154075openalex-snapshot
Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database
inferredcites →https://doi.org/10.1186/s13054-014-0462-8openalex-snapshot
Omeprazole-associated rhabdomyolysis
inferredcites →https://doi.org/10.1186/s13054-016-1314-5openalex-snapshot
Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice
inferredcites →https://doi.org/10.1213/ane.0000000000005096openalex-snapshot
Basic Science of Frailty—Biological Mechanisms of Age-Related Sarcopenia
inferredcites →https://doi.org/10.1345/1542-6270(2002)036<0288:faeros>2.0.co;2openalex-snapshot
FDA Adverse Event Reports on Statin-Associated Rhabdomyolysis
inferredcites →https://doi.org/10.1345/aph.1c396openalex-snapshot
Rhabdomyolysis Causing AV Blockade Due to Possible Atorvastatin, Esomeprazole, and Clarithromycin Interaction
inferredcites →https://doi.org/10.1345/aph.1g382openalex-snapshot
Acute Severe Myopathy Following a Single Infusion of Omeprazole
inferredcites →https://doi.org/10.1517/14740338.2013.832752openalex-snapshot
Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature
inferredcites →https://doi.org/10.1517/14740338.4.5.929openalex-snapshot
The role of data mining in pharmacovigilance
inferredcites →https://doi.org/10.1586/17512433.2013.811206openalex-snapshot
Perils and pitfalls of long-term effects of proton pump inhibitors
inferredcites →https://doi.org/10.2165/00002018-200225060-00001openalex-snapshot
Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database
inferredcites →https://doi.org/10.2169/internalmedicine.50.4484openalex-snapshot
Characteristics of Drug-Associated Rhabdomyolysis: Analysis of 8,610 Cases Reported to the U.S. Food and Drug Administration
inferredcites →https://doi.org/10.3389/fcvm.2022.767987openalex-snapshot
Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study
inferredcites →https://doi.org/10.5009/gnl15502openalex-snapshot
25 Years of Proton Pump Inhibitors: A Comprehensive Review
inferredcites →https://doi.org/10.7150/ijms.6048openalex-snapshot
Data Mining of the Public Version of the FDA Adverse Event Reporting System
inferredcites →https://doi.org/10.7326/m21-3393openalex-snapshot
Moving the U.S. Food and Drug Administration Forward
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4832604openalex-extracted
Medication -Induced Rhabdomyolysis: A Disproportionality Analysis of the FAERS Data
inferred← citeshttps://doi.org/10.1080/14740338.2025.2490847openalex-snapshot
Dementia-related adverse events associated with direct oral anticoagulants use: a real-world, pharmacovigilance study based on the FAERS database
inferred← citeshttps://doi.org/10.1136/ejhpharm-2024-004253openalex-snapshot
HMGCR-associated myopathy in polymorbid patients with polypharmacy should not be attributed solely to statins
inferred← citeshttps://doi.org/10.1371/journal.pone.0340684openalex-snapshot
Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database
inferred← citeshttps://doi.org/10.26442/20751753.2024.1.202532openalex-snapshot
Cardiovascular risk with long-term use of proton pump inhibitors: myth or reality. A review
inferred← citeshttps://doi.org/10.3389/fphar.2025.1526836openalex-snapshot
Drug-induced dermatomyositis: a pharmacovigilance study of the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.3389/fphar.2025.1582908openalex-snapshot
Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study
inferred← citeshttps://doi.org/10.3389/fphar.2026.1852621openalex-snapshot
Muscle toxicity reports in FAERS: a disproportionality analysis with focus on rhabdomyolysis and cross-database assessment
inferred← citeshttps://doi.org/10.3390/genes16030248openalex-snapshot
The Association Between Statin Drugs and Rhabdomyolysis: An Analysis of FDA Adverse Event Reporting System (FAERS) Data and Transcriptomic Profiles
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.